https://www.nrn.com/menu/lettuce-entertain-you-shares-new-initiatives-eggs-grill-makes-menu-moves-and-dish-pizza-styles
Apr 30, 2024 - Menu Talk: Pat and Bret dig into the latest food and drink trends and restaurant news
0
nrn:5173576563519048628
0
https://www.startribune.com/building-construction-house-apartment-home-real-estate-residential-mortgage-rate-financing/600362764/
Apr 30, 2024 - At a time when there's already a shortage of housing in many parts of the metro, apartment developers have received only enough permits to build 115 apartments and other multifamily units, 55% fewer than last year.
0
sb:-7900904542200789509
0
https://www.zacks.com/stock/news/2265390/martin-marietta-mlm-q1-earnings-beat-estimates-2024-view-up?cid=CS-ZC-FT-analyst_blog|earnings_article-2265390
Apr 30, 2024 - Martin Marietta's (MLM) first-quarter results reflect lower volumes despite strong pricing actions.
zc:-2460212478641254294
0
https://seekingalpha.com/article/4687370-ares-capital-investment-attractiveness-increased-despite-share-price-runup?source=feed_all_articles
Apr 29, 2024 - Ares Capital has become a more enticing investment, especially compared to most other BDCs. See why ARCC stock is a Buy.
0
sa:-9043099192187050131
0
https://www.zacks.com/stock/news/2264332/amphenol-aph-is-up-9-37-in-one-week-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_10-2264332
Apr 29, 2024 - Does Amphenol (APH) have what it takes to be a top stock pick for momentum investors? Let's find out.
zc:1033184951372959312
0
https://www.zacks.com/stock/news/2264393/domino-s-dpz-q1-earnings-revenues-beat-estimates-stock-up?cid=CS-ZC-FT-analyst_blog|earnings_article-2264393
Apr 29, 2024 - Domino's' (DPZ) fiscal first-quarter performance benefits from Hungry for MORE strategy and the updated Domino's Rewards loyalty program.
zc:8878593502577223997
0
https://www.zacks.com/stock/news/2264391/moderna-mrna-gears-up-for-q1-earnings-here-s-what-to-expect?cid=CS-ZC-FT-analyst_blog|earnings_article-2264391
Apr 29, 2024 - Investors' focus will likely be on updates on Moderna's (MRNA) expected RSV vaccine launch and its late-stage pipeline candidates when it reports first-quarter earnings.
zc:248949341476254570
0
https://www.zacks.com/stock/news/2264265/brinker-eat-gears-up-for-q3-earnings-what-s-in-the-cards?cid=CS-ZC-FT-analyst_blog|earnings_preview-2264265
Apr 29, 2024 - Brinker's (EAT) fiscal third-quarter performance is likely to have benefited from Chili's performance, development efforts and marketing initiatives. Higher expenses and weather woes are a concern.
zc:8116382752162035579
0
https://www.zacks.com/stock/news/2264258/powell-powl-gears-up-to-post-q2-earnings-is-a-beat-likely?cid=CS-ZC-FT-analyst_blog|earnings_preview-2264258
Apr 29, 2024 - Powell's (POWL) second-quarter fiscal 2024 results are expected to benefit from solid momentum across petrochemical, oil and gas sectors, partly offset by cost inflation.
zc:-4454524785038601972
0
https://www.rttnews.com/story.aspx?Id=3442645
Apr 29, 2024 - Shares of Deciphera Pharmaceuticals, Inc. (DCPH) were surging more than 70 percent in pre-market on Monday to $25.03 after the company announced its decision to be acquired by ONO Pharmaceutical Co., Ltd. for about $2.4 billion, to be paid in cash.
0
rttnews:64649990461542414
0